MODUL—a multicenter randomized clinical trial of biomarker-driven maintenance therapy following first-line standard induction treatment of metastatic colorectal cancer: an adaptable signal-seeking approach
Year: 2018
Type: article
Institutions: Martin Luther University Halle-Wittenberg, Hôpital Saint-Antoine, Université Paris-Saclay, Institut Gustave Roussy, Mayo Clinic, Abramson Cancer Center, University of Pennsylvania, KU Leuven, F. Hoffmann-La Roche AG, Molecular Partners (Switzerland), Universitat Autònoma de Barcelona, Vall d'Hebron Hospital Universitari, Vall d'Hebron Institute of Oncology
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funder: F. Hoffmann-La Roche
OpenAlex ID: W2797610990
